» Articles » PMID: 16289860

TGF-beta and Cancer

Overview
Date 2005 Nov 18
PMID 16289860
Citations 203
Authors
Affiliations
Soon will be listed here.
Abstract

TGF-beta signaling regulates tumorigenesis and in human cancer its signaling pathways are often modified during tumor progression. Prior to initiation and early during progression TGF-beta acts upon the epithelium as a tumor suppressor, however at later stages it is often a tumor promoter. Over the years, many studies have focused on the epithelial cell autonomous role for TGF-beta, however, TGF-beta is not strictly limited to this compartment in vivo. Recent studies addressing TGF-beta mediated stromal-epithelial interactions have significantly improved our understanding related to the regulation of cancer. In addition, stromal fibroblast cell autonomous effects have been observed in response to TGF-beta stimulation. According to the current literature and experimental evidence, TGF-beta is a potent ligand that regulates carcinoma initiation, progression and metastasis through a broad and complex spectrum of interdependent interactions.

Citing Articles

Endothelial-to-mesenchymal transition in the tumor microenvironment: Roles of transforming growth factor-β and matrix metalloproteins.

Du F, Li J, Zhong X, Zhang Z, Zhao Y Heliyon. 2024; 10(21):e40118.

PMID: 39568849 PMC: 11577214. DOI: 10.1016/j.heliyon.2024.e40118.


Remodeling tumor microenvironment using pH-sensitive biomimetic co-delivery of TRAIL/R848 liposomes against colorectal cancer.

Huang Y, Wang J, Xu J, Ruan N Oncol Res. 2024; 32(11):1765-1776.

PMID: 39449815 PMC: 11497182. DOI: 10.32604/or.2024.045564.


Oncogenic mechanisms of COL10A1 in cancer and clinical challenges (Review).

Yi Q, Zhu G, Zhu W, Wang J, Ouyang X, Yang K Oncol Rep. 2024; 52(6).

PMID: 39392043 PMC: 11487528. DOI: 10.3892/or.2024.8821.


Pan-cancer analysis suggests that LY6H is a potential biomarker of diagnosis, immunoinfiltration, and prognosis.

Qin H, Lu H, Qin C, Huang X, Peng K, Li Y J Cancer. 2024; 15(17):5515-5539.

PMID: 39308669 PMC: 11414603. DOI: 10.7150/jca.98449.


Construct prognostic models of multiple myeloma with pathway information incorporated.

Wang S, Wang S, Pan W, Yi Y, Lu J PLoS Comput Biol. 2024; 20(9):e1012444.

PMID: 39255326 PMC: 11414978. DOI: 10.1371/journal.pcbi.1012444.